Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.61
-0.03 (-0.39%)
Jun 18, 2025, 9:42 AM - Market open
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Bicycle Therapeutics stock have a consensus rating of "Buy" and an average price target of $25, which forecasts a 228.52% increase in the stock price over the next year. The lowest target is $14 and the highest is $48.
Price Target: $25 (+228.52%)
Analyst Consensus: Buy
* Price targets were last updated on May 6, 2025.
Analyst Ratings
The average analyst rating for Bicycle Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 8 | 8 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +123.39% | May 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +320.50% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | +83.97% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $26 → $22 | Buy | Maintains | $26 → $22 | +189.09% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +281.08% | May 2, 2025 |
Financial Forecast
Revenue This Year
38.04M
from 35.28M
Increased by 7.83%
Revenue Next Year
34.99M
from 38.04M
Decreased by -8.01%
EPS This Year
-3.77
from -2.90
EPS Next Year
-4.48
from -3.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 57.7M | 69.3M | 144.3M | ||
| Avg | 38.0M | 35.0M | 81.3M | ||
| Low | 15.7M | n/a | 18.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.7% | 82.1% | 312.4% | ||
| Avg | 7.8% | -8.0% | 132.4% | ||
| Low | -55.6% | - | -46.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.44 | -4.20 | -2.84 | ||
| Avg | -3.77 | -4.48 | -3.77 | ||
| Low | -4.01 | -5.25 | -4.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.